Thermo Fisher Scientific (TMO) Assets Average (2009 - 2026)

Thermo Fisher Scientific has reported Assets Average for 18 years, with the latest figure at $113.2 billion in Q2 2026.

• Assets Average for Q2 2026 came in at $113.2 billion, up 13.07% year-over-year; the trailing twelve-month figure through Jun 2026 was $113.2 billion (up 13.07% YoY), and the FY2025 annual result was $103.8 billion, up 5.93% from the prior year.
• Assets Average improved to $113.2 billion in Q2 2026, from $111.8 billion in the prior quarter.
• Over five years, Assets Average peaked at $113.2 billion in Q2 2026 and troughed at $90.6 billion in Q4 2022.
• A 5-year average of $98.9 billion and a median of $97.9 billion in 2023 frame the typical range for Assets Average.
• The widest annual swing landed in 2022, when Assets Average surged 39.18%; it then grew 0.28% in 2025.
• A 5-year view of Assets Average shows it stood at $93.8 billion in 2022, then grew by 4.31% to $97.9 billion in 2023, then increased by 0.97% to $98.8 billion in 2024, then grew by 7.93% to $106.7 billion in 2025, then gained by 6.14% to $113.2 billion in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $113.2 billion in Q2 2026, $111.8 billion in Q1 2026, and $106.7 billion in Q4 2025.